Shares of Balchem BCPC remained unaffected after the company reported Q1 results.
Earnings per share increased 7.41% over the past year to $0.87, which beat the estimate of $0.84.
Revenue of $185,656,000 rose by 6.43% year over year, which beat the estimate of $181,590,000.
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Apr 30, 2021
Time: 11:00 AM
Company's 52-week high was at $132.50
52-week low: $79.75
Price action over last quarter: Up 2.51%
Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil and gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.